Curaleaf Holdings, Inc. announced on November 10, 2026, that it has secured all required competition law clearances for its proposed acquisition of Aurora Cannabis Inc. The company received approvals from regulators in Germany and Canada, the only jurisdictions where clearance was necessary for the deal.
In Germany, the Federal Ministry for Economic Affairs and Energy granted approval on October 20, 2026, to acquire 100% of the voting rights in Aurora Europe GmbH, Aurora Deutschland GmbH, and Aurora Produktions GmbH. Additionally, the Federal Cartel Office confirmed on November 3, 2026, that the acquisition does not meet the conditions for prohibition under German competition law.
In Canada, the Competition Bureau issued a no-action letter on November 2, 2026, confirming that the interim commissioner does not intend to make an application regarding the proposed acquisition of Aurora's common shares.
Curaleaf’s enhanced premium bid, which was announced on October 6, 2026, remains outstanding and is set to expire on December 4, 2026, unless withdrawn or amended. The company stated that these clearances provide greater certainty of completion and support a faster path to closing, subject to the Offer's remaining conditions being satisfied or waived.
